Pancreatic perfusion: noninvasive quantitative assessment with dynamic contrast-enhanced MR imaging without and with secretin stimulation in healthy volunteers--initial results.

PURPOSE To prospectively quantify pancreatic regional perfusion with dynamic contrast material-enhanced magnetic resonance (MR) imaging by using a one-compartment model and to assess perfusion changes during secretin stimulation in healthy volunteers. MATERIALS AND METHODS The study had institutional review board approval, and written informed consent was obtained. Ten healthy volunteers (five men, five women; mean age, 24.7 years +/- 1.9 [standard deviation]; range, 22-29 years) underwent MR imaging pancreatic perfusion studies performed twice without secretin and twice during secretin stimulation. Dynamic contrast-enhanced MR imaging consisted of saturation-recovery T1-weighted turbo-field-echo imaging with peripheral pulse triggering and respiratory tracking. A dose of 0.05 mmol gadodiamide per kilogram of body weight was injected at a rate of 3.5 mL/sec. Regional perfusion parameters were fitted with a one-compartment model. The analysis of variance test for repeated measurements was used to assess differences in pancreatic perfusion without and that with secretin administration. RESULTS Significant differences in perfusion parameters between the three pancreatic regions were observed (P < .05). During secretin stimulation, a significant difference was observed only between the body and the tail of the pancreas (P = .02). A significant increase (P = .003) in pancreatic perfusion was observed after secretin administration. Mean pancreatic perfusion was 184 mL/min/100 g of tissue +/- 71, 207 mL/min/100 g +/- 77, and 230 mL/min/100 g +/- 87 without secretin and 342 mL/min/100 g +/- 154, 338 mL/min/100 g +/- 156, and 373 mL/min/100 g +/- 176 after secretin stimulation in the head, body, and tail of the pancreas, respectively. Intraindividual variability was 21% without secretin stimulation and 46% with secretin stimulation. CONCLUSION Dynamic contrast-enhanced MR imaging enables noninvasive quantification of regional pancreatic perfusion in resting conditions and demonstrates the increase in pancreatic perfusion during secretin stimulation in healthy subjects.

[1]  R. S. Chung,et al.  The Effect of Secretin on Pancreatic Blood Flow in the Awake and Anesthetized Dog , 1983, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[2]  J. Delaney,et al.  Influence of hormones and drugs on canine pancreatic blood flow. , 1966, The American journal of physiology.

[3]  M. Knopp,et al.  Estimating kinetic parameters from dynamic contrast‐enhanced t1‐weighted MRI of a diffusable tracer: Standardized quantities and symbols , 1999, Journal of magnetic resonance imaging : JMRI.

[4]  H. Reber,et al.  Pancreatic vascular regulation in chronic pancreatitis in cats. , 1995, Gut.

[5]  B. V. Van Beers,et al.  Hepatic flow parameters measured with MR imaging and Doppler US: correlations with degree of cirrhosis and portal hypertension. , 2003, Radiology.

[6]  J. Furui,et al.  Use of the time–signal intensity curve from dynamic magnetic resonance imaging to evaluate remnant pancreatic fibrosis after pancreaticojejunostomy in patients undergoing pancreaticoduodenectomy , 2004, The British journal of surgery.

[7]  F. Maes,et al.  Dynamic contrast‐enhanced MRI of the pancreas: Initial results in healthy volunteers and patients with chronic pancreatitis , 2004, Journal of magnetic resonance imaging : JMRI.

[8]  L. Gates,et al.  Restrospecitve analysis of the effect of contrast enhanced CT on the outcome of acute pancreatitis , 1995 .

[9]  C. Becker,et al.  Perfusion measurement in acute pancreatitis using dynamic perfusion MDCT. , 2006, AJR. American journal of roentgenology.

[10]  T. Hwang,et al.  Contrast-enhanced dynamic computed tomography does not aggravate the clinical severity of patients with severe acute pancreatitis: reevaluation of the effect of intravenous contrast medium on the severity of acute pancreatitis. , 2000, Archives of surgery.

[11]  R. Lucht,et al.  Microcirculation and microvasculature in breast tumors: Pharmacokinetic analysis of dynamic MR image series , 2004, Magnetic resonance in medicine.

[12]  Laurent Hermoye,et al.  Inflow correction of hepatic perfusion measurements using T1‐weighted, fast gradient‐echo, contrast‐enhanced MRI , 2004, Magnetic resonance in medicine.

[13]  B. V. Van Beers,et al.  Assessment of hepatic perfusion parameters with dynamic MRI , 2002, Magnetic resonance in medicine.

[14]  Y. Yonekura,et al.  Assessment of pancreatic blood flow with positron emission tomography and oxygen-15 water , 1991, Annals of nuclear medicine.

[15]  W. Schenk,et al.  Hemodynamics of pancreatic secretion. With observations on pancreatic oxygen consumption. , 1966, Archives of surgery.

[16]  J. Cuppen,et al.  RLSQ: T1, T2, and ρ calculations, combining ratios and least squares , 1987 .

[17]  Fuminori Moriyasu,et al.  Differential diagnosis of pancreatic tumors using ultrasound contrast imaging , 2005, Journal of Gastroenterology.

[18]  R. Carmona-Sánchez,et al.  Potential harmful effect of iodinated intravenous contrast medium on the clinical course of mild acute pancreatitis. , 2000, Archives of surgery.

[19]  L. Semb,et al.  The effect of secretin and pancreozymin on pancreatic blood flow in the conscious and anesthetized dog. , 1969, Acta physiologica Scandinavica.

[20]  P. Holton,et al.  Some observations on changes in the blood content of the cat's pancreas during activity , 1960, The Journal of physiology.

[21]  A K Dixon,et al.  Measurement of human pancreatic perfusion using dynamic computed tomography with perfusion imaging. , 1995, The British journal of radiology.

[22]  G. Zamboni,et al.  Ultrasonography of the pancreas. 4. Contrast-enhanced imaging , 2007, Abdominal Imaging.